This Practice Point commentary discusses the study by Denzinger et al. in which patients with high-grade T1 (HGT1) bladder cancer were treated by transurethral resection with either white-light ...

Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

Minimally invasive treatments of symptomatic benign prostatic hyperplasia (BPH) have been adopted by many centers for treatment of patients who fail pharmacological manipulation and cannot or do not ...

In patients with suspected muscle-invasive bladder cancer (MIBC), definitive treatment can be expedited by adding multi-parametric magnetic resonance imaging (mpMRI) to flexible cystoscopic biopsy at ...

Please provide your email address to receive an email when new articles are posted on . Transurethral resection of bladder tumor plus systemic therapy induced clinical complete response among a large ...

Accurate documentation of lesions during transurethral resection of bladder tumors (TURBT) is essential for precise diagnosis, treatment planning, and follow-up care. However, optimizing schematic ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

A cystoscopy is a test to check the health of your urethra and bladder. You might also hear it called a cystourethroscopy or, more simply, a bladder scope. It’s an outpatient test, which means you can ...

The effect of repeated cystoscopy on bladder cancer (BC) patient anxiety and feelings is rarely evaluated. To compare the difference of patients' anxiety and subjective feelings caused by different ...

Standard intra-urethral instillation of anaesthetic gel may not sufficiently exclude pain perception during cystoscopy. To evaluate the impact of the anaesthesia within the posterior urethra on pain ...